Literature DB >> 26181401

Gastric gastrointestinal stromal tumor smaller than 20 mm with liver metastasis.

Akira Aso1, Eikichi Ihara2, Hiroaki Kubo2, Takashi Osoegawa2, Takamasa Oono2, Kazuhiko Nakamura2, Tetuhide Ito2, Yoshihiro Kakeji3, Osada Mikako4, Hedetaka Yamamoto4, Tatsuhiro Oishi5, Yayoi Oishi5, Yoichi Hachitanda6, Ryoichi Takayanagi2.   

Abstract

There have been no reports of gastric gastrointestinal stromal tumors (GISTs) <20 mm with distant metastasis. We report a case of a 15-mm gastric GIST with liver metastasis 1 year after surgical resection of the primary lesion. A 35-year-old man underwent routine esophagogastroduodenoscopy in July 2009. A submucosal tumor (SMT) <20 mm was incidentally detected at the posterior wall of the gastric body. Endoscopic ultrasound (EUS) indicated that it was a gastrointestinal mesenchymal tumor, including GIST, leiomyoma or schwannoma. He did not accept regular follow-up for this gastric SMT, therefore local laparoscopic excision was carried out in October 2009. The final pathological diagnosis after surgery was GIST, 15 mm in size, and a mitotic rate of 7/50 high-power fields, which did not indicate a high metastatic risk. The patient was followed up regularly without adjuvant chemotherapy. At 1 year after surgery, a space-occupying lesion ~15 mm was detected in the left lobe of the liver by abdominal ultrasound, where no mass lesion had been observed before surgery. To make a definite diagnosis of the hepatic mass lesion, EUS-guided fine-needle aspiration was performed, which demonstrated a metastatic liver tumor from a gastric GIST. Although this was a rare case, we should keep in mind that gastric GISTs do have a chance of malignant behavior, even if <20 mm.

Entities:  

Keywords:  Gastrointestinal stromal tumor; Liver metastases; Malignant tumor

Year:  2013        PMID: 26181401     DOI: 10.1007/s12328-012-0351-0

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  14 in total

Review 1.  Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.

Authors:  Michael C Heinrich; Brian P Rubin; B Jack Longley; Jonathan A Fletcher
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

Review 2.  Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Authors:  P G Casali; L Jost; P Reichardt; M Schlemmer; J-Y Blay
Journal:  Ann Oncol       Date:  2009-05       Impact factor: 32.976

3.  Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.

Authors:  L G Kindblom; H E Remotti; F Aldenborg; J M Meis-Kindblom
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

Review 4.  Gastrointestinal stromal tumors: pathology and prognosis at different sites.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  Semin Diagn Pathol       Date:  2006-05       Impact factor: 3.464

Review 5.  The role of KIT in the management of patients with gastrointestinal stromal tumors.

Authors:  Jason L Hornick; Christopher D M Fletcher
Journal:  Hum Pathol       Date:  2007-05       Impact factor: 3.466

Review 6.  Gastrointestinal stromal tumor (GIST) and imatinib.

Authors:  Tetsuro Kubota
Journal:  Int J Clin Oncol       Date:  2006-06       Impact factor: 3.402

7.  Endoscopic ultrasonography for gastric submucosal lesions.

Authors:  Ioannis S Papanikolaou; Konstantinos Triantafyllou; Anastasia Kourikou; Thomas Rösch
Journal:  World J Gastrointest Endosc       Date:  2011-05-16

8.  Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.

Authors:  Michael C Heinrich; Robert G Maki; Christopher L Corless; Cristina R Antonescu; Amy Harlow; Diana Griffith; Ajia Town; Arin McKinley; Wen-Bin Ou; Jonathan A Fletcher; Christopher D M Fletcher; Xin Huang; Darrel P Cohen; Charles M Baum; George D Demetri
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

Review 9.  Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

Review 10.  Diagnostic procedures for submucosal tumors in the gastrointestinal tract.

Authors:  Laura-Graves Ponsaing; Katalin Kiss; Annika Loft; Lise-Ingemann Jensen; Mark-Berner Hansen
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

View more
  9 in total

1.  Diagnostic ability of a 22G Franseen needle in endoscopic ultrasound-guided fine needle aspiration of subepithelial lesions.

Authors:  Akashi Fujita; Shomei Ryozawa; Masanori Kobayashi; Ryuichiro Araki; Koji Nagata; Kazuhiro Minami; Yuki Tanisaka; Tsutomu Kobatake; Masafumi Mizuide
Journal:  Mol Clin Oncol       Date:  2018-09-03

2.  Comparison of submucosal tunneling biopsy versus EUS-guided FNA for gastric subepithelial lesions: a prospective study with crossover design.

Authors:  Hideki Kobara; Hirohito Mori; Naoki Nishimoto; Shintaro Fujihara; Noriko Nishiyama; Maki Ayaki; Tatsuo Yachida; Tae Matsunaga; Taiga Chiyo; Nobuya Kobayashi; Koji Fujita; Kiyohito Kato; Hideki Kamada; Makoto Oryu; Kunihiko Tsutsui; Hisakazu Iwama; Reiji Haba; Tsutomu Masaki
Journal:  Endosc Int Open       Date:  2017-08-03

3.  EUS-guided sampling with 25G biopsy needle as a rescue strategy for diagnosis of small subepithelial lesions of the upper gastrointestinal tract.

Authors:  Filippo Antonini; Sara Giorgini; Lorenzo Fuccio; Lucia Angelelli; Giampiero Macarri
Journal:  Endosc Int Open       Date:  2018-07-04

4.  Efficacy of Mucosal Cutting Biopsy for the Histopathological Diagnosis of Gastric Submucosal Tumors.

Authors:  Akihisa Adachi; Yoshikazu Hirata; Hayato Kawamura; Takahito Harada; Reika Hattori; Daisuke Kumai; Yuki Yamamoto; Yuki Kojima; Hirokazu Ikeuchi; Noriyuki Hayashi; Hisato Mochizuki; Hiroki Takada; Ryuzo Yamaguchi; Satoshi Sobue
Journal:  Case Rep Gastroenterol       Date:  2019-04-09

5.  Examine the Availability and Safety of Mucosal Cutting Biopsy Technique for Diagnosis of Gastric Submucosal Tumor.

Authors:  Kazuhiro Mizukami; Osamu Matsunari; Ryo Ogawa; Yuka Hirashita; Kazuhisa Okamoto; Kensuke Fukuda; Akira Sonoda; Hidetoshi Akiyama; Sotaro Ozaka; Yoshinari Kawahara; Tadayoshi Okimoto; Masaaki Kodama; Kazunari Murakami
Journal:  Gastroenterol Res Pract       Date:  2019-05-02       Impact factor: 2.260

6.  Utility of a 20G needle with a core trap in EUS-guided fine-needle biopsy for gastric submucosal tumors: A multicentric prospective trial.

Authors:  Ken Kamata; Akira Kurita; Satoru Yasukawa; Yasutaka Chiba; Hiroko Nebiki; Masanori Asada; Hiroaki Yasuda; Hideyuki Shiomi; Takeshi Ogura; Makoto Takaoka; Noriyuki Hoki; Reiko Ashida; Minoru Shigekawa; Akio Yanagisawa; Masatoshi Kudo; Masayuki Kitano
Journal:  Endosc Ultrasound       Date:  2021 Mar-Apr       Impact factor: 5.628

Review 7.  The Diagnosis of Small Gastrointestinal Subepithelial Lesions by Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy.

Authors:  Masanari Sekine; Takeharu Asano; Hirosato Mashima
Journal:  Diagnostics (Basel)       Date:  2022-03-25

Review 8.  Current clinical management of gastrointestinal stromal tumor.

Authors:  Kazuya Akahoshi; Masafumi Oya; Tadashi Koga; Yuki Shiratsuchi
Journal:  World J Gastroenterol       Date:  2018-07-14       Impact factor: 5.742

9.  Superiority of mucosal incision-assisted biopsy over ultrasound-guided fine needle aspiration biopsy in diagnosing small gastric subepithelial lesions: a propensity score matching analysis.

Authors:  Yosuke Minoda; Takatoshi Chinen; Takashi Osoegawa; Soichi Itaba; Kazuhiro Haraguchi; Hirotada Akiho; Akira Aso; Yorinobu Sumida; Keishi Komori; Haruei Ogino; Eikichi Ihara; Yoshihiro Ogawa
Journal:  BMC Gastroenterol       Date:  2020-01-21       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.